Bioactivity of natural biflavonoids in metabolism-related disease and cancer therapies.
Pharmacol Res
; 167: 105525, 2021 05.
Article
en En
| MEDLINE
| ID: mdl-33667686
Palabras clave
2,3-Dihydroamentoflavone (Pubchem CID-44420106); 2',8â³-Biapigenin (Pubchem CID-11958336); 3,8â³-Biapigenin (Pubchem CID-10414856); 6,6â³-Biapigenin (Pubchem CID-23757236); 7,7â³-Dimethoxyagastisflavone (Pubchem CID-9985405); Agathisflavone (Pubchem CID-5281599); Alzheimer's; Amentoflavone (Pubchem CID-5281600); Angiogenesis; Anticancer; Apoptosis induction; Biacacetin (Pubchem CID-122179776); Biflavonoids; Bilobetin (Pubchem CID-5315459); Bioavailability; Chamaejasmenin B (Pubchem CID-21676273); Diabetic agent; Dihydromorelloflavone (Pubchem CID-11467081); Fatty acid synthase; Fukugeside (Pubchem CID-101560895); Ginkgetin (Pubchem CID-5271805); Glucosidase inhibition; Hinokiflavone (Pubchem CID-5281627); Isochamaejasmenin B (Pubchem CID-11753405); Isoginkgetin (Pubchem CID-5318569); Metastasis; Morelloflavone (Pubchem CID-5464454); Obesity therapy; Ochnaflavone (Pubchem CID-5492110); PPAR-γ expression; PTP1B inhibitors; Pancreatic lipase; Sciadopitysin (Pubchem CID-5281696); Taiwaniaflavone (Pubchem CID-44456685); Volkensiflavone (Pubchem CID-5480834)
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Biflavonoides
/
Enfermedades Metabólicas
/
Neoplasias
/
Antineoplásicos Fitogénicos
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Pharmacol Res
Asunto de la revista:
FARMACOLOGIA
Año:
2021
Tipo del documento:
Article
País de afiliación:
Japón